Frontiers in Research on Neurodegenerative Disorders in Edinburgh

Harness Therapeutics Research Scientist Fay Humphries will be attending Frontiers in Research on Neurodegenerative Disorders in Edinburgh on 10 September.

The conference will explore advances across Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia and ALS, with topics including genetics, disease mechanisms, biomarkers and therapeutics.

We look forward to hearing the latest insights shaping neurodegenerative disease research.

If you're joining the conference, we'd love to connect — come and say hello!

#Neurodegeneration #Neuroscience #DrugDiscovery #HarnessTherapeutics

Our programmes

Huntington's Disease

Discover more

ALS and Alzheimer's

Discover more

Parkinson’s Disease

Discover more

Our news

June 2026

Harness Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance Parkinson's Disease Programme

February 2026

Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntington’s Disease and Establishes Clinical Advisory Board

October 2025

Harness Therapeutics Announces Launch of MISBA® Duo Platform and Research Collaboration with Ono Venture Investment

June 2025

Harness Therapeutics Publishes HTT CAG Repeat Sizing Methodology Code on GitHub

View all